For any further information
Who we are
Resono Ophthalmic is an Italian company that produces highly innovative therapeutic devices for the eye-care domain. The key feature of these devices is the exploitation of Quantum Molecular Resonance (QMR®), a patented technique capable of stimulating the natural cellular and tissue regeneration via low-power high-frequency electric fields.
Our Mission
Our mission is to contribute to improving the quality of patient’s life by providing ground-breaking solutions that effectively treat a range of eye syndromes and diseases.Reinvent Dry Eye Treatment
Rexon-Eye is a non-invasive device that provides durable treatment for all forms of dry eye syndromes. It works by applying low-power high-frequency electric fields, capable of stimulating the metabolism and natural regeneration of cells.
The treatment addresses all types of the dry eye syndromes, both evaporative and hypo-secretive, as evidenced by several subjective and objective measurements.
Newsroom
Resono at ACOS conference to present QMR technology | Paris, 18th September
With a speech on QMR® technology for Ophthalmology, Resono will be participating in the round...
Latest Rexon-Eye clinical trial presentation
RESONO OPHTHALMIC has just participated to the ARVO 2021 Annual Meeting with a presentation about...
Resono at MEOM – Middle Est Ophthalmology Meeting
RESONO Ophthalmic has been invited to the 2nd episode of Cataract series sessions of MEOM Middle...